Language: 简体中文 English
Invited Speaker

Tao Cheng

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, China

Update time:2020-10-14 18:00

Tao Cheng is currently a professor of medicine at Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS), president of  Institute of Hematology & Blood Diseases Hospital at CAMS, director of State Key Laboratory of Experimental Hematology, and also the founding chairman of Department of Stem Cell and Regenerative Medicine at PUMC, the founding director of Center for Stem Cell Medicine at CAMS and the founding president of Chinese Association for Blood Sciences (CABS).

Prof. Cheng received his medical degrees from Second Military Medical University in Shanghai, China (1981-1989). He did his residency in internal Medicine and clinical fellowship in Hematology at Changhai Hospital, Shanghai, China (1989-1993). He received his postgraduate research training at Hipple Cancer Research Center, Dayton, Ohio and Massachusetts General Hospital, Boston, Massachusetts (1993-1997). He became an instructor in Medicine in 1998, then an assistant professor in 2001 at Harvard University, an associate professor with tenure (2006-2010) and later a full professor at University of Pittsburgh School of Medicine (2010-2013).

Prof. Cheng‘s laboratory primarily focuses on both genetic and epigenetic mechanisms in hematopoietic stem and progenitor cells, with each project guided by approaches intended to elucidate basic principles and develop practical strategies. Leukemia and bone marrow failure are the main diseases against which research advances in the laboratory are achieved. Through broadly collaborative approaches, Prof. Cheng is also committed to training hematologists and stem cell biologists, and to building strong hematology and stem cell research programs that will ultimately benefit the patients.

Prof. Cheng is the founding editor-in chief of Blood Science, the first English fundamental hematology journal in China. He has been in the editorial board of several leading journals in hematology and stem cell research including Blood, Leukemia, Experimental Hematology (associate editor) and International Journal of Hematology (associate editor).

Congress has ended
Important Dates
Virtual Congress Dates
Wednesday to Thursday
November 18-19, 2020

Online Registration Deadline
November 19, 2020